# Situation: A 50-year-old woman with generalized anxiety disorder attends an outpatient mental health clinic. She has taken diazepam 5 mg orally three times daily for 8 months. Her psychiatrist plans to taper the diazepam slowly and start buspirone. She asks how soon buspirone will start to relieve her anxiety. What should the nurse tell her?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=630209  
> language: ko  
> subject: Nursing Practice V — Care of Clients with Maladaptive Patterns of Behavior; Care of Clients with Life-Threatening Conditions, Acute Multi-Organ Problems, High Acuity and Emergency Situations

## 문제

Situation: A 50-year-old woman with generalized anxiety disorder attends an outpatient mental health clinic. She has taken diazepam 5 mg orally three times daily for 8 months. Her psychiatrist plans to taper the diazepam slowly and start buspirone.

She asks how soon buspirone will start to relieve her anxiety. What should the nurse tell her?

## 보기

1. Only after 6 to 8 weeks
2. In about 2 to 4 weeks **✔ 정답**
3. Within 2 to 3 days
4. Within 30 to 60 minutes

**정답: 2**

## 해설

Buspirone is a serotonin 5-HT1A partial agonist whose anxiolytic effect builds gradually, beginning after about 2–4 weeks of regular use, unlike the rapid effect of a benzodiazepine.

## 심화 해설

Buspirone has a fundamentally different onset profile from diazepam, and this difference is central to safe cross-tapering in generalized anxiety disorder. The nurse should explain that buspirone is a serotonin 5-HT1A partial agonist, not a benzodiazepine receptor agonist. Its anxiolytic effect develops gradually as receptor adaptation and downstream serotonergic modulation occur, so meaningful relief typically begins after about 2 to 4 weeks of consistent dosing .

The patient has been taking diazepam 5 mg three times daily for 8 months. Diazepam produces rapid symptom relief through GABA-A receptor potentiation, often within 30 to 60 minutes of an oral dose. Buspirone does not act on the GABA-A receptor complex and lacks the immediate calming effect that patients accustomed to benzodiazepines may expect . Because buspirone does not provide immediate anxiolysis, it cannot be substituted abruptly for diazepam during a taper; the benzodiazepine must be withdrawn slowly while buspirone levels and receptor effects build over several weeks.

A common clinical pitfall is assuming that all anxiolytics work with the same speed. Watch out! Buspirone is not a prn or rapid-onset agent. If the patient expects relief within hours or days, she may perceive treatment failure and discontinue the medication prematurely. The nurse should set a realistic expectation of 2 to 4 weeks for initial response, with full therapeutic benefit often requiring longer .

The delayed onset also has implications for cross-tapering safety. During the first several weeks of buspirone initiation, the patient still depends on diazepam for symptom control. Abrupt benzodiazepine discontinuation during this window can precipitate withdrawal symptoms and rebound anxiety, because buspirone has not yet achieved its therapeutic effect. The psychiatrist’s plan for a slow diazepam taper is therefore pharmacologically rational: it allows buspirone’s serotonergic effects to accumulate while benzodiazepine exposure is gradually reduced .

Buspirone’s side-effect profile also differs from diazepam. It produces less sedation, less psychomotor impairment, and less potentiation of alcohol, and it carries a lower potential for dependence or abuse . However, these advantages do not translate into faster onset. Key point! The onset of anxiolytic action and the side-effect profile are separate pharmacological properties. A drug with fewer sedative effects is not necessarily faster-acting.

The comparison between the two agents can be summarized as follows:

| Property | Buspirone | Diazepam |
| --- | --- | --- |
| Primary mechanism | Serotonin 5-HT1A partial agonist | GABA-A receptor positive allosteric modulator |
| Onset of anxiolytic effect | About 2 to 4 weeks of regular use | Within 30 to 60 minutes |
| Sedation and psychomotor impairment | Less pronounced | More pronounced |
| Dependence and abuse potential | Lower | Higher |
| Role in cross-taper | Started while benzodiazepine is tapered slowly | Tapered gradually to avoid withdrawal |

The patient’s question about timing is clinically important because it reveals her expectation of symptom relief. The nurse should explain that buspirone requires regular daily dosing and that the first 2 to 4 weeks may not bring noticeable improvement. This is not a sign of treatment failure but rather the expected pharmacodynamic delay of a serotonergic anxiolytic . During this period, the slow diazepam taper continues to provide coverage, and the patient should be monitored for both benzodiazepine withdrawal symptoms and emerging buspirone response .

## 임상 시나리오

Setting Expectations for Buspirone OnsetEducating patients during benzodiazepine cross-taper
Buspirone is a serotonin 5-HT1A partial agonist, not a benzodiazepine. Its anxiolytic effect builds gradually, with initial relief typically beginning after 2 to 4 weeks of consistent dosing.

In contrast, diazepam acts on GABA-A receptors and provides rapid relief within 30 to 60 minutes. Patients accustomed to this quick effect may perceive buspirone as ineffective early in treatment.

CautionBuspirone cannot be used as a prn or rapid-onset agent. Abrupt substitution for diazepam during a taper is unsafe; the benzodiazepine must be withdrawn slowly while buspirone's effects develop over several weeks.

## 핵심 개념

- **Buspirone** — A serotonin 5-HT1A partial agonist used for anxiety, with a delayed onset of action of about 2-4 weeks.
- **Diazepam** — A benzodiazepine that rapidly potentiates GABA-A receptors, providing quick anxiolytic effects within 30-60 minutes.
- **Cross-tapering** — A strategy of gradually withdrawing one medication while introducing another to minimize withdrawal and relapse.
- **5-HT1A partial agonist** — A drug mechanism that modulates serotonin receptors, leading to gradual anxiolytic effects through receptor adaptation.

## 같은 주제 문제

- [Situation: A 29-year-old man is admitted to the psychiatric unit of a general hospital aft…](https://mymerci.kr/pages/nclex_q.php?qn_id=629986)
- [Situation: A 29-year-old man is admitted to the psychiatric unit of a general hospital aft…](https://mymerci.kr/pages/nclex_q.php?qn_id=629987)
- [Situation: A 29-year-old man is admitted to the psychiatric unit of a general hospital aft…](https://mymerci.kr/pages/nclex_q.php?qn_id=629988)
- [Situation: A 29-year-old man is admitted to the psychiatric unit of a general hospital aft…](https://mymerci.kr/pages/nclex_q.php?qn_id=629989)
- [Situation: A 52-year-old man is seen at the outpatient mental health clinic of a provincia…](https://mymerci.kr/pages/nclex_q.php?qn_id=629990)
- [Situation: A 52-year-old man is seen at the outpatient mental health clinic of a provincia…](https://mymerci.kr/pages/nclex_q.php?qn_id=629991)
- [Situation: A 52-year-old man is seen at the outpatient mental health clinic of a provincia…](https://mymerci.kr/pages/nclex_q.php?qn_id=629992)
- [Situation: A 40-year-old woman is admitted to the psychiatric ward with major depressive d…](https://mymerci.kr/pages/nclex_q.php?qn_id=629993)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._